Phase I clinical, pharmacokinetic, and pharmacodynamic study of KOS-862 (Epothilone D) in patients with advanced solid tumors and lymphoma.
about
Phase I clinical, pharmacokinetic, and pharmacodynamic study of KOS-862 (Epothilone D) in patients with advanced solid tumors and lymphoma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Phase I clinical, pharmacokine ...... ced solid tumors and lymphoma.
@en
Phase I clinical, pharmacokine ...... ced solid tumors and lymphoma.
@nl
type
label
Phase I clinical, pharmacokine ...... ced solid tumors and lymphoma.
@en
Phase I clinical, pharmacokine ...... ced solid tumors and lymphoma.
@nl
prefLabel
Phase I clinical, pharmacokine ...... ced solid tumors and lymphoma.
@en
Phase I clinical, pharmacokine ...... ced solid tumors and lymphoma.
@nl
P2093
P2860
P1476
Phase I clinical, pharmacokine ...... ced solid tumors and lymphoma.
@en
P2093
Alison L Hannah
Carol Aghajanian
David Hyman
David R Spriggs
Gillian Cropp
Jakob Dupont
Martee L Hensley
Owen A O'Connor
Paul Sabbatini
P2860
P2888
P304
P356
10.1007/S10637-011-9765-7
P50
P577
2011-11-10T00:00:00Z